FDA Investigator Thomas J Mooney

Thomas J Mooney has conducted inspections on 176 sites in 2 countries as of 10 Nov 2009. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
176
Last Inspection Date:
10 Nov 2009
Investigator Role:
FDA Investigator
Redica ID:
100003973
Countries of Inspections:
United States of America, Japan
FDA Investigators that have inspected at least one site in common with Thomas J Mooney:
Alice S Tsao, Althea A Williams, Amatul H Marium, Amber D Brodas, Amy Wyan Mai, Andrew Byro, Andrew F Cohen, Andrew J Garufi, Andrew M Abramowitz, Ann B Okon, Ann L Demarco, Ann M Stewart, Arduino Frankovic, Arthur G Hurst, Avital A Shimanovich, Betty M Ng Lee, Bijoy Panicker, Brandy N Lepage, Brian M Brodman, Brian S Keefer, Burnell M Henry, Carrie E Jolly, Cary Greene, Charanjeet Jassal, Charisse K Green, Christian Parra, Christine M Rivera, Christopher S Fields, Daniel L Zheng, Daniel T Lee, Daniel W Johnson, Danna E Solorzano, Dave M Deroche, David R Delucia, Deborah J Parris, Dell S Moller, Demitria J Xiradakis, Devon O Seymour, Dilijeta Bajrami, Dipesh K Shah, Donald J Ullstrom, Dongping Dai, PhD, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Edouard Viard, Erica B Brush, Erica B Raphael, Evelyn Taha, Felix Maldonado, Frank Verni, Gam S Zamil, Gary J Lehr, Gary T Greco, Gregson A Joseph, Guerlain Ulysse, Helen B Ricalde, Ilana Zigelman, Iram R Hassan, PhD, Jackson Y See, Jacqueline S Warner, James A Liubicich, Jana J Lau, Jane C Chen, Jason D Tenney, Jay T Wong, Jazmine N Brown, Jazmine N Still, Jeffrey J Thibodeau, Jogy George, Jose Ohernandez Guzman, Joseph Duca, Joseph Maselli, Joseph Milcetic, Joy P Matthias, Juan Rjimenez Garcia, Juanita P Versace, Judy Friedman, Juliana Falla, Justin A Boyd, Karen L Kosar, Karishma G Gopaul, Kenneth H Williams, Kevin A Gonzalez, Kimberley A Ricketts, Kimberly Y Smithson, Kwong P Lee, Lawrence W Farina, Loretta J Miller, Marie B Buen Bigornia, Melissa N Gregorio, Meredith P Soehl, Investigator, Michael A Charles, Michael G Sinkevich, Michael R Dominick, Michele L Obert, Mindy M Chou, Nada F Agabani, Nariman Patenaude, Nazmul Hassan, Neil J Bonzagni, PhD MPH, Nerizza B Guerin, Nicole Vaught, Otto D Vitillo, Parul M Patel, Patrick C Klotzbuecher, Paul E Stein, Paul Mouris, Perez, Peter Abel, Peter M Trunk, Peter R Caparelli, Philip F Istafanos, DMV, MS, Phyllis J Wilson, Rachael A Moliver, Raymond M Lam, Robert C Howard, Robert C Steyert, Robert E Moncayo, Robert J Veitch, Ronald Ifraimov, Samina S Khan, Samuel A Francis, Samuel T Walker, Sarah A Meehan, Sarah A Wangseng, Satheesh Thomas, Shantelle I Hughes, Shari L Kahn, Shreya Shah, Simone E Pitts, Sony Mathews, Sou Chan Chang, Stephanie T Durso, Steven M Weinman, Sunita Vij, Susan M Joseph, Susan T Hadman, Susan W Ting, Syeda N Mahazabin, Tanya R Syffrard, Tara K Normandin, Ted L Anderson, Terry Bridgewater, Thomas E Friel, Thomas J Mccrey, Tiffany S Allison, Tracy M Portelli, Uduak M Inokon, Valerie A Potopsingh, Wai H Lam, Wayne J Meyer, Wayne S Fortenberry, Yuyan Liang, Yvonne M Santiago

Thomas J Mooney's Documents

Publish Date Document Type Title
September, 2003 FDA 483 PDK Labs, Inc - Form 483, 2003-09-22
March, 2007 FDA 483 Pharbest Pharmaceuticals, Inc. - Form 483, 2007-03-08
February, 2006 EIR LNK International, Inc. - EIR, 2006-08-30
October, 2003 EIR Amneal Pharmaceuticals of New York, LLC - EIR, 2003-10-10
January, 2003 EIR Corwood Labs Inc - EIR, 2003-01-29
April, 2000 EIR Nestle Health Science, LLC. - EIR, 2000-04-06
July, 2002 FDA 483 Altaire Pharmaceuticals Inc. - Form 483, 2002-07-25
May, 2003 EIR Gemini Pharmaceuticals, Inc. dba Plus Pharma - EIR, 2003-05-30
February, 2006 EIR LNK International, Inc. - EIR, 2006-02-16
May, 2003 EIR Contract Pharmacal Corporation - EIR, 2003-05-08
October, 2003 FDA 483 Takeda Pharmaceutical Company Limited - Form 483, 2003-10-24
October, 2003 EIR Takeda Pharmaceutical Company Limited - EIR, 2003-12-18
February, 2006 FDA 483 LNK International, Inc. - Form 483, 2006-02-16
July, 2006 EIR Advance Pharmaceutical, Inc. - EIR, 2006-07-26
February, 2004 EIR NBTY Inc. - EIR, 2004-02-17
February, 2009 EIR Gemini Pharmaceuticals, Inc. dba Plus Pharma - EIR, 2009-02-05

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more